12:00 AM
 | 
Dec 11, 2000
 |  BC Week In Review  |  Company News  |  Deals

PPL, Bristol-Myers deal

PTH acquired exclusive global rights to BMY's production technology for fibrin I sealants derived from fibrinogen to stop bleeding and seal wounds. PTH will...

Read the full 96 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >